Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 610631, 4 pages
http://dx.doi.org/10.1100/2012/610631
Research Article

Physiologically Based Structure of Mean Residence Time

The Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, 84104 Bratislava, Slovakia

Received 31 October 2011; Accepted 28 December 2011

Academic Editor: Gian Maria Pacifici

Copyright © 2012 Mária Ďurišová. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Verotta, “Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems,” Critical Reviews in Biomedical Engineering, vol. 24, no. 2-3, pp. 73–139, 1996. View at Google Scholar · View at Scopus
  2. M. Weiss and K. S. Pang, “Dynamics of drug distribution. I. Role of the second and third curve moments,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 20, no. 3, pp. 253–278, 1992. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Dedík and M. Ďurišová, “CXT-MAIN: a software package for determination of the analytical form of the pharmacokinetic system weighting function,” Computer Methods and Programs in Biomedicine, vol. 51, no. 3, pp. 183–192, 1996. View at Publisher · View at Google Scholar
  4. M. Ďurišová, L. Dedík, and M. Balan, “Building a structured model of a complex pharmacokinetic system with time delays,” Bulletin of Mathematical Biology, vol. 57, no. 6, pp. 787–808, 1995. View at Publisher · View at Google Scholar
  5. M. Ďurišová and L. Dedík, “Modeling in frequency domain used for assessment of in vivo dissolution profile,” Pharmaceutical Research, vol. 14, no. 7, pp. 860–864, 1997. View at Publisher · View at Google Scholar
  6. M. Ďurišová and L. Dedík, “New mathematical methods in pharmacokinetic modeling,” Basic and Clinical Pharmacology and Toxicology, vol. 96, no. 5, pp. 335–342, 2005. View at Publisher · View at Google Scholar
  7. J. Chrenova, M. Durisova, C. Mircioiu, and L. Dedik, “Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine,” Methods and Findings in Experimental and Clinical Pharmacology, vol. 32, no. 6, pp. 413–419, 2010. View at Publisher · View at Google Scholar
  8. P. J. Eddershaw, A. P. Beresford, and M. K. Bayliss, “ADME/PK as part of a rational approach to drug discovery,” Drug Discovery Today, vol. 5, no. 9, pp. 409–414, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Cobelli and G. Toffolo, “Compartmental vs. noncompartmental modeling for two accessible pools,” American Journal of Physiology, vol. 247, no. 3, pp. R488–R496, 1984. View at Google Scholar
  10. D. J. Cutler, “A linear recirculation model for drug disposition,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 7, no. 1, pp. 101–116, 1979. View at Google Scholar · View at Scopus
  11. K. Yamaoka, T. Nakagawa, and T. Uno, “Statistical moments in pharmacokinetics,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 6, no. 6, pp. 547–558, 1978. View at Publisher · View at Google Scholar · View at Scopus
  12. M. S. Roberts and Y. G. Anissimov, “Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 27, no. 4, pp. 343–382, 1999. View at Google Scholar · View at Scopus
  13. A. Mari, “Circulatory models of intact-body kinetics and their relationship with compartmental and non-compartmental analysis,” Journal of Theoretical Biology, vol. 160, no. 4, pp. 509–531, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Weiss, “Pharmacokinetics in organs and the intact body: model validation and reduction,” European Journal of Pharmaceutical Sciences, vol. 7, no. 2, pp. 119–127, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Weiss and W. Foerster, “Pharmacokinetic model based on circulatory transport,” European Journal of Clinical Pharmacology, vol. 16, no. 4, pp. 287–293, 1979. View at Google Scholar · View at Scopus
  16. M. Weiss, M. Reekers, J. Vuyk, and F. Boer, “Circulatory model of vascular and interstitial distribution kinetics of rocuronium: a population analysis in patients,” Journal of Pharmacokinetics and Pharmacodynamics, vol. 38, no. 2, pp. 165–178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Gaohua and H. Kimura, “Simulation of propofol anaesthesia for intracranial decompression using brain hypothermia treatment,” Theoretical Biology and Medical Modelling, vol. 4, article 46, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Capderou, “New techniques for the study of pulmonary circulation,” Revue des Maladies Respiratoires, vol. 16, supplement 3, pp. S103–S104, 1999. View at Google Scholar · View at Scopus
  19. N. Méndez-Sánchez, H. Sánchez-Gómez, E. Rojas, and M. Uribe, “Pylephlebitis of portal venous system associated with urinary infection,” Digestive Diseases and Sciences, vol. 48, no. 4, pp. 834–836, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. M. E. Valentinuzzi, “A mathematical model of the hepatic portal system,” Medical and Biological Engineering, vol. 9, no. 3, pp. 213–220, 1971. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Rowland, “Physiologic pharmacokinetic models and interanimal species scaling,” Pharmacology and Therapeutics, vol. 29, no. 1, pp. 49–68, 1985. View at Google Scholar · View at Scopus
  22. T. A. Shepard, G. F. Lockwood, L. J. Aarons, and I. D. Abrahams, “Mean residence time for drugs subject to enterohepatic cycling,” Journal of Pharmacokinetics and Biopharmaceutics, vol. 17, no. 3, pp. 327–345, 1989. View at Google Scholar · View at Scopus
  23. M. Tvrdonova, L. Dedik, C. Mircioiu, D. Miklovicova, and M. Durisova, “Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings,” Basic and Clinical Pharmacology and Toxicology, vol. 104, no. 1, pp. 35–42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Veng-Pedersen, “Noncompartmentally-based pharmacokinetic modeling,” Advanced Drug Delivery Reviews, vol. 48, no. 2-3, pp. 265–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Waterhouse and J. Keilson, “Transfer times across the human body,” The Bulletin of Mathematical Biophysics, vol. 34, no. 1, pp. 33–44, 1972. View at Publisher · View at Google Scholar · View at Scopus